Sintx Technologies (SINT) Competitors $3.49 +0.23 (+7.06%) Closing price 08/22/2025 03:59 PM EasternExtended Trading$3.38 -0.11 (-3.12%) As of 08/22/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SINT vs. COCH, VVOS, RVP, FEMY, PETV, ICU, DRIO, NXGL, IRIX, and ALURShould you be buying Sintx Technologies stock or one of its competitors? The main competitors of Sintx Technologies include Envoy Medical (COCH), Vivos Therapeutics (VVOS), Retractable Technologies (RVP), Femasys (FEMY), PetVivo (PETV), SeaStar Medical (ICU), DarioHealth (DRIO), NexGel (NXGL), IRIDEX (IRIX), and Allurion Technologies (ALUR). These companies are all part of the "medical equipment" industry. Sintx Technologies vs. Its Competitors Envoy Medical Vivos Therapeutics Retractable Technologies Femasys PetVivo SeaStar Medical DarioHealth NexGel IRIDEX Allurion Technologies Sintx Technologies (NASDAQ:SINT) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings. Do analysts prefer SINT or COCH? Sintx Technologies currently has a consensus target price of $28.00, indicating a potential upside of 702.29%. Envoy Medical has a consensus target price of $9.25, indicating a potential upside of 704.35%. Given Envoy Medical's higher possible upside, analysts clearly believe Envoy Medical is more favorable than Sintx Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sintx Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Envoy Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to SINT or COCH? In the previous week, Envoy Medical had 1 more articles in the media than Sintx Technologies. MarketBeat recorded 1 mentions for Envoy Medical and 0 mentions for Sintx Technologies. Sintx Technologies' average media sentiment score of 0.90 beat Envoy Medical's score of -0.36 indicating that Sintx Technologies is being referred to more favorably in the media. Company Overall Sentiment Sintx Technologies Positive Envoy Medical Neutral Is SINT or COCH more profitable? Sintx Technologies has a net margin of -674.05% compared to Envoy Medical's net margin of -10,961.26%. Envoy Medical's return on equity of 0.00% beat Sintx Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Sintx Technologies-674.05% -256.59% -121.32% Envoy Medical -10,961.26%N/A -236.14% Do institutionals & insiders have more ownership in SINT or COCH? 18.4% of Sintx Technologies shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 4.1% of Sintx Technologies shares are owned by insiders. Comparatively, 58.9% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has better valuation & earnings, SINT or COCH? Sintx Technologies has higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Sintx Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSintx Technologies$950K10.14-$11.02M-$50.56-0.07Envoy Medical$220K112.49-$20.80M-$1.43-0.80 Which has more volatility and risk, SINT or COCH? Sintx Technologies has a beta of 0.65, suggesting that its stock price is 35% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.21, suggesting that its stock price is 121% more volatile than the S&P 500. SummaryEnvoy Medical beats Sintx Technologies on 8 of the 15 factors compared between the two stocks. Get Sintx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SINT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SINT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SINT vs. The Competition Export to ExcelMetricSintx TechnologiesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.99M$6.82B$5.75B$9.62BDividend YieldN/A1.31%4.40%4.10%P/E Ratio-0.0727.4531.2526.05Price / Sales10.1475.47433.91193.97Price / CashN/A21.3437.7358.48Price / Book2.416.889.536.61Net Income-$11.02M$176.42M$3.26B$265.65M7 Day Performance14.80%1.45%2.13%2.03%1 Month Performance26.91%-2.71%2.80%-0.31%1 Year Performance-19.03%9.40%30.68%19.06% Sintx Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SINTSintx Technologies2.7913 of 5 stars$3.49+7.1%$28.00+702.3%-18.6%$8.99M$950K-0.0740Short Interest ↓High Trading VolumeCOCHEnvoy Medical3.0416 of 5 stars$1.35-4.9%$9.25+585.2%-58.3%$30.56M$220K-0.9434Gap UpHigh Trading VolumeVVOSVivos Therapeutics1.3079 of 5 stars$4.45+8.3%$4.82+8.2%+59.1%$24.21M$15.03M-2.57160News CoverageEarnings ReportGap DownRVPRetractable Technologies1.8431 of 5 stars$0.80+0.7%N/A-12.9%$23.96M$38.16M-1.48240FEMYFemasys3.2362 of 5 stars$0.70-1.4%$7.33+947.5%-43.5%$23.13M$1.63M-0.8130Gap UpPETVPetVivoN/A$0.82+1.7%N/A+54.5%$22.63M$1.05M-1.8320Gap DownICUSeaStar Medical0.091 of 5 stars$0.83+3.2%N/A-87.5%$22.44M$140K-0.322DRIODarioHealth1.2585 of 5 stars$0.45+0.4%$2.00+344.6%-37.4%$20.38M$27.04M-0.68200NXGLNexGel1.1195 of 5 stars$2.31-4.9%N/A-16.2%$19.60M$8.69M-5.7710IRIXIRIDEX1.5607 of 5 stars$1.17+3.5%N/A-36.3%$19.20M$48.67M-3.55120Positive NewsALURAllurion Technologies2.9361 of 5 stars$2.38-1.0%$22.83+861.4%-86.0%$17.90M$32.11M-0.19501Earnings ReportGap Up Related Companies and Tools Related Companies COCH Alternatives VVOS Alternatives RVP Alternatives FEMY Alternatives PETV Alternatives ICU Alternatives DRIO Alternatives NXGL Alternatives IRIX Alternatives ALUR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SINT) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sintx Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sintx Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access